指南与共识慢性肾脏病肾血管病与高血压

采用2017年美国儿科学会指南后慢性肾脏病儿童血压分类状况

Blood Pressure Classification Status in Children With CKD Following Adoption of the 2017 American Academy of Pediatrics Guideline.
指南 / 共识 · Am J Kidney Dis · 2022-12-12

该观察性队列研究在CKiD队列中比较2017年美国儿科学会(AAP)儿童高血压指南与2004年第四次报告对血压分类的影响。结果发现,采用2017年AAP指南的规范数据后,更多患儿被分类为1-2期高血压(22% vs 11%),且2017年指南判定的2期高血压患儿蛋白尿水平更高。动态血压监测分类的可重复性良好(κ=0.799)。

要点

  • 采用2017年AAP指南规范数据,更多CKiD患儿被分类为1-2期高血压(22% vs 11%)。
  • 2017年指南判定的2期高血压患儿蛋白尿水平高于2004年报告判定者。
  • 动态血压监测分类的可重复性良好(κ=0.799 [95% CI, 0.778-0.819])。

核心结论

  • 采用2017年AAP指南与2004年第四次报告相比,更多CKiD患儿在诊室和动态血压监测中均被识别为高血压,且2017年指南更好地区分了蛋白尿水平较高的患儿。

研究设计与样本

  • 观察性队列研究,研究对象为CKiD队列中的儿童和青少年,暴露为诊室血压测量。

主要发现

  • 采用2017年指南与2004年报告分类为诊室血压正常的儿童比例相似,但2017年指南将更多参与者分类为1-2期高血压(22% vs 11%),可重复性一般(κ=0.569 [95% CI, 0.538-0.599])。
  • 2017年指南判定的2期高血压患儿蛋白尿水平高于2004年报告判定者。
  • 比较2017年指南与2004年报告对动态血压监测分类:白大衣高血压为3.5% vs 1.5%,动态高血压为15.5% vs 7.9%,隐匿性高血压为40.2% vs 47.8%,血压正常为40.9% vs 42.9%。
  • 动态血压监测分类的整体可重复性良好(κ=0.799 [95% CI, 0.778-0.819])。

局限性

  • 未评估与长期进展及靶器官损害的关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Accurate detection of hypertension is crucial for clinical management of pediatric chronic kidney disease (CKD). The 2017 American Academy of Pediatrics (AAP) clinical practice guideline for childhood hypertension included new normative blood pressure (BP) values and revised definitions of BP categories. In this study, we examined the effect of applying the AAP guideline's normative data and definitions to the Chronic Kidney Disease in Children (CKiD) cohort compared with use of normative data and definitions from the 2004 Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. STUDY DESIGN: Observational cohort study. SETTING & PARTICIPANTS: Children and adolescents in the CKiD cohort. EXPOSURE: Clinic BP measurements. OUTCOME: BP percentiles and hypertension stages calculated using the 2017 AAP guideline and the Fourth Report from 2004. ANALYTICAL APPROACH: Agreement analysis compared the estimated percentile and prevalence of high BP based on the 2017 guideline and 2004 report to clinic and combined ambulatory BP readings. RESULTS: The proportion of children classified as having normal clinic BP was similar using the 2017 and 2004 systems, but the use of the 2017 normative data classified more participants as having stages 1-2 hypertension (22% vs 11%), with marginal reproducibility (κ=0.569 [95% CI, 0.538-0.599]). Those identified as having stage 2 hypertension by the 2017 guideline had higher levels of proteinuria compared with those identified using the 2004 report. Comparing use of the 2017 guideline and the 2004 report in terms of ambulatory BP monitoring categories, there were substantially more participants with white coat (3.5% vs 1.5%) and ambulatory (15.5% vs 7.9%) hypertension, but the proportion with masked hypertension was lower (40.2% vs 47.8%, respectively), and the percentage of participants who were normotensive was similar (40.9% vs 42.9%, respectively). Overall, there was good reproducibility (κ=0.799 [95% CI, 0.778-0.819]) of classification by ambulatory BP monitoring. LIMITATIONS: Relationship with long-term progression and target organ damage was not assessed. CONCLUSIONS: A greater percentage of children with CKD were identified as having hypertension based on both clinic and ambulatory BP when using the 2017 AAP guideline versus the Fourth Report from 2004, and the 2017 guideline better discriminated those with higher levels of proteinuria. The substantial differences in the classification of hypertension when using the 2017 guideline should inform clinical care.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Ng DK, Carroll MK, Furth SL, et al. Blood Pressure Classification Status in Children With CKD Following Adoption of the 2017 American Academy of Pediatrics Guideline. Am J Kidney Dis. 2022. PMID: 36521780. doi:10.1053/j.ajkd.2022.10.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。